Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

PAI-2 helps in the maturation and protection of hair and nail cells.

Thyroid hormones are important for skin health and might help treat skin diseases, but more research is needed to understand their effects fully.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Cronkhite-Canada Syndrome often leads to death within 6-18 months.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

Rabbits lacking the Hoxc13 gene show similar hair and skin issues to humans with ECTD-9, making them good for research on this condition.

The document concludes that a new training model could improve dermatology residents' skills in nail procedures and lead to more nail cases being treated by dermatologists.

Scalp alopecia areata mostly affects young adult males, often starts suddenly, and usually presents as single, patchy lesions.

The document concludes that stem cells and their environments are crucial for skin and hair health and have potential for medical treatments.

The patient's hair loss is most likely due to diffuse alopecia areata.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Mutations in the HOXC13 gene cause hair and nail development issues.

Thyroid hormone affects skin health, with too little causing rough, pale skin and too much leading to smooth, thin skin, and may also impact wound healing and skin conditions.

A new mouse gene, Keratin 17n, is mainly found in nail tissue and may explain why mice without Keratin 17 don't have nail issues.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Human nails and hair follicles have similar gene activity, especially in the cells that contribute to their growth and development.

Scalp biopsies are important for diagnosing hair loss conditions.

Higher IL-17A levels indicate more severe alopecia areata.

The HoxC gene cluster and its enhancers are essential for developing hair and nails in mammals.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Certain compounds can boost hair and nail growth.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Skin problems are common and important signs of eating disorders and treating the eating disorder can improve these skin conditions.

Hair loss requires customized treatments based on its various causes and types.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.